Task 105627
BPC-157 (10mg)
99.765% purity reported
Evidence cluster
Tissue, Copper-Peptide & Mitochondrial Research
Connected evidence records for short signalling peptides, copper complexes and mitochondrial-derived or mitochondria-targeting compounds, with counter-evidence and model limitations retained.
Research frame
Questions this cluster is built to answer
- 01Is the evidence about the exact compound, a parent protein or only a related fragment?
- 02Are endogenous biomarker observations being confused with intervention evidence?
- 03What do newer or limiting studies add to the original mechanistic story?
Compound evidence records
Evidence dossier
MOTS-C
A model-by-model guide to MOTS-C research, separating its original cellular and mouse findings from later human observational work and unresolved questions.
Open recordEvidence dossier
SS-31
A research guide to SS-31/elamipretide naming, cardiolipin-related mechanisms, early human trials and the gap between mechanistic and clinical evidence.
Open recordEvidence dossier
KPV
A model-specific guide to KPV nomenclature and the mainly cellular and animal evidence surrounding this short alpha-MSH-derived tripeptide.
Open recordEvidence dossier
TB-500
An identity-focused guide explaining why TB-500 should not be treated as a synonym for full-length thymosin beta-4 and what analytical studies actually found.
Open recordEstablished guide
BPC-157
A source-led reading of rat-derived tendon and cell experiments, including what they cannot establish about human recovery.
Open recordEstablished guide
GHK-Cu
A guide to foundational copper-uptake research that separates cellular findings, material identity and formulation claims.
Open recordEstablished guide
NAD+
A guide to distinguishing NAD+ from precursor interventions, using a verified human NMN study and its actual metabolic endpoints.
Open recordMethods and connected analysis
Research Insights
GHK-Cu Research Guide: Copper Complexes and Study Context
Understand the distinction between a copper-binding research finding, a peptide formulation and a claim about skin outcomes.
Research Insights
NAD+ Research: Separating the Molecule, Precursors and Human Evidence
Learn why an NMN or NR precursor study cannot be treated as a study of every NAD+ preparation, with a verified human trial example.
Research Insights
BPC-157 Research Overview: Tendon Models and Evidence Limits
A source-led look at a BPC-157 tendon study, distinguishing tissue outgrowth, cell migration and survival from human healing claims.
Document navigation
Published analytical records in this topic
Each record transcribes a published laboratory document and states its limits. A document is not treated as proof of the current inventory lot.
Task 95742
GHK-Cu (50mg)
99.715% purity reported
Task 123367
SS-31 (10mg)
99.922% purity reported
Task 100077
MOTS-C (10mg)
99.542% purity reported
Task 123506
GHK-Cu (100mg)
99.814% purity reported
Task 124507
KLOW Peptide Blend (80mg)
4 composition results published
Task 103228
MOTS-C (40mg)
99.647% / 99.653% / 99.498% purity reported
Catalogue context
Related public catalogue collections
These links organise public laboratory catalogue records by research subject. Catalogue availability is not evidence for a therapeutic outcome.